Patients with poorly controlled hypertension | Patients with poorly controlled dyslipidemia | Patients with poorly controlled diabetes mellitus | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
6 Months | 12 Months | 6 Months | 12 Months | 6 Months | 12 Months | |||||||
n | % | n | % | n | % | n | % | n | % | n | % | |
Appropriate clinical action | 211 | 54.0 | 240 | 61.4 | 67 | 29.0 | 87 | 37.7 | 46 | 78.0 | 50 | 84.7 |
Any therapy modification | 193 | 49.4 | 238 | 60.9 | 55 | 23.8 | 77 | 33.3 | 44 | 74.6 | 50 | 84.7 |
Increase class | 121 | 30.9 | 153 | 39.1 | 43 | 18.6 | 64 | 27.7 | 26 | 44.1 | 30 | 50.8 |
Increase dose | 103 | 26.3 | 135 | 34.5 | 15 | 6.5 | 23 | 10.0 | 31 | 52.5 | 36 | 61.0 |
Switch class† | 30 | 7.7 | 49 | 12.5 | 0 | 0.0 | 2 | 0.9 | 6 | 10.2 | 10 | 16.9 |
Several modifications | 55 | 14.1 | 88 | 22.5 | 3 | 1.3 | 11 | 4.8 | 19 | 32.2 | 26 | 44.1 |
Return to control WO modification‡ | 18 | 4.6 | 2 | 0.5 | 12 | 5.2 | 10 | 4.3 | 2 | 3.4 | 0 | 0.0 |
Inappropriate clinical action | 180 | 46.0 | 151 | 38.6 | 164 | 71.0 | 144 | 62.3 | 13 | 22.0 | 9 | 15.3 |
No modification, return to near control‡ | 25 | 6.4 | 9 | 2.3 | 38 | 16.5 | 27 | 11.7 | 1 | 1.7 | 3 | 5.1 |
No modification, no return‡ | 120 | 30.7 | 134 | 34.3 | 40 | 17.3 | 40 | 17.3 | 7 | 11.9 | 2 | 3.4 |
No measurement, no modification | 35 | 9.0 | 8 | 2.0 | 86 | 37.2 | 77 | 33.3 | 5 | 8.5 | 4 | 6.8 |